This review delineates these non-canonical mechanisms, emphasizing PCSK9's roles in vascular inflammation, atherosclerosis, thrombosis, regulated cardiomyocyte death, and calcific aortic valve disease (CAVD). Here, PCSK9 is linked to congenital bilateral aplasia of vas deferens from CFTR mutation.